Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Siglec15em1/Cya
Common Name:
Siglec15-KO
Product ID:
S-KO-11239
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Siglec15-KO
Strain ID
KOCMP-620235-Siglec15-B6N-VA
Gene Name
Siglec15
Product ID
S-KO-11239
Gene Alias
Cd33l3; EG620235; SIGLEC-I
Background
C57BL/6NCya
NCBI ID
620235
Modification
Conventional knockout
Chromosome
18
Phenotype
MGI:3646642
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Siglec15em1/Cya mice (Catalog S-KO-11239) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000170760
NCBI RefSeq
NM_001101038
Target Region
Exon 2~5
Size of Effective Region
~3.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Siglec15, a sialic acid-binding immunoglobulin-like lectin, has emerged as a significant molecule in the immune-tumor interaction landscape. It is involved in immune evasion mechanisms, mainly by suppressing T lymphocyte activation and proliferation, and is also implicated in osteoclast differentiation and bone remodeling [2]. In the tumor microenvironment (TME), it can shape a non-inflamed state, influencing cancer progression and response to immunotherapy.

In bladder cancer, overexpression of Siglec15 leads to reduced CD8+ T cell infiltration by downregulating pro-inflammatory cytokines and chemokines, exacerbating malignancy and contributing to immune evasion [6]. In breast cancer, osteoclast-derived apoptotic bodies inhibit naive CD8+ T cell activation via Siglec15, promoting secondary metastasis [1]. In anaplastic thyroid cancer, blocking Siglec15 with an antibody increases the cytotoxic ability of CD8+ T cells, inhibits tumor growth, and prolongs mouse survival [3]. In pancreatic cancer, Siglec15+ tumor-associated macrophages (TAMs) present an M2-like phenotype, accelerating tumor growth and immunosuppressive microenvironment [4]. In hepatocellular carcinoma, Siglec15 promotes immune evasion by inducing CD8+ T cell apoptosis [5]. In non-small cell lung cancer, Siglec15 knockdown inhibits cell proliferation, migration, and invasion, and down-regulation of Siglec15 in tumor cells enhances the antitumor immune responses of CD8+ T cells [7].

In conclusion, Siglec15 plays a crucial role in immune evasion and tumor progression across multiple cancer types. Mouse models, especially those involving gene knockout (KO) or conditional knockout (CKO) of Siglec15, have been instrumental in revealing its functions in specific disease conditions, highlighting its potential as a therapeutic target for cancer immunotherapy.

References:

1. Wu, Yutong, Ai, Hongbo, Xi, Yuhang, Luo, Fei, Dou, Ce. 2023. Osteoclast-derived apoptotic bodies inhibit naive CD8+ T cell activation via Siglec15, promoting breast cancer secondary metastasis. In Cell reports. Medicine, 4, 101165. doi:10.1016/j.xcrm.2023.101165. https://pubmed.ncbi.nlm.nih.gov/37607544/

2. Fan, Yujia, Sun, Liangliang, He, Juan, Ma, Hongli, Ding, Haitao. 2024. Siglec15 in blood system diseases: from bench to bedside. In Frontiers in immunology, 15, 1490505. doi:10.3389/fimmu.2024.1490505. https://pubmed.ncbi.nlm.nih.gov/39697338/

3. Bao, Lisha, Li, Ying, Hu, Xiaoping, Ge, Minghua, Pan, Zongfu. 2024. Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer. In International immunopharmacology, 133, 112102. doi:10.1016/j.intimp.2024.112102. https://pubmed.ncbi.nlm.nih.gov/38652971/

4. Li, Tian-Jiao, Jin, Kai-Zhou, Li, Hao, Yu, Xian-Jun, Wu, Wei-Ding. 2022. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. In Cancer letters, 530, 142-155. doi:10.1016/j.canlet.2022.01.026. https://pubmed.ncbi.nlm.nih.gov/35077803/

5. Chen, Zheng, Yu, Mincheng, Zhang, Bo, Li, Hui, Guo, Lei. 2024. SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion. In Oncoimmunology, 13, 2376264. doi:10.1080/2162402X.2024.2376264. https://pubmed.ncbi.nlm.nih.gov/38988824/

6. Deng, Dingshan, Xiao, Jiatong, Liu, Jinhui, Hu, Jiao, Zu, Xiongbing. 2024. Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer. In Journal of hematology & oncology, 17, 117. doi:10.1186/s13045-024-01638-2. https://pubmed.ncbi.nlm.nih.gov/39609852/

7. Liang, Haifeng, Chen, Qing, Hu, Zhichao, Jiang, Libo, Dong, Jian. . Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis. In Annals of translational medicine, 10, 281. doi:10.21037/atm-22-764. https://pubmed.ncbi.nlm.nih.gov/35434017/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest